Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | August 24, 2023 09:06am

Gainers

  • CollPlant Biotechnologies (NASDAQ:CLGN) shares increased by 27.8% to $8.0 during Thursday's pre-market session. The company's market cap stands at $91.1 million. The company's, Q2 earnings came out today.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares rose 25.93% to $0.19. The company's market cap stands at $2.6 million.
  • Taysha Gene Therapies (NASDAQ:TSHA) stock rose 15.29% to $2.56. The company's market cap stands at $165.0 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) shares rose 13.72% to $1.16. The market value of their outstanding shares is at $2.7 million.
  • Nemaura Medical (NASDAQ:NMRD) stock increased by 11.9% to $0.46. The market value of their outstanding shares is at $13.2 million.
  • Aytu BioPharma (NASDAQ:AYTU) stock increased by 11.11% to $1.89. The market value of their outstanding shares is at $10.4 million.

Losers

  • Societal CDMO (NASDAQ:SCTL) shares decreased by 30.9% to $0.42 during Thursday's pre-market session. The market value of their outstanding shares is at $37.8 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) shares decreased by 14.15% to $0.54. The company's market cap stands at $3.8 million.
  • OKYO Pharma (NASDAQ:OKYO) shares declined by 13.2% to $1.71. The market value of their outstanding shares is at $43.6 million.
  • Meihua Intl Medical Techs (NASDAQ:MHUA) stock fell 10.56% to $3.39. The company's market cap stands at $81.1 million.
  • Avalo Therapeutics (NASDAQ:AVTX) stock declined by 9.76% to $0.09. The market value of their outstanding shares is at $1.8 million.
  • Vincerx Pharma (NASDAQ:VINC) shares declined by 9.64% to $0.75. The company's market cap stands at $16.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVTX AYTU CLGN KPRX MHUA NBSE NMRD OKYO SCTL SXTC TSHA VINC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist